IPO Boutique

Ardelyx Inc., IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Ardelyx Inc.,, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Ardelyx Inc.,ARDX -
NASDAQ
$13.00-$15.00 $14.00 $14.504.3 million6/19/2014
Citigroup, Leerink Partners
Co-Manager(s):
JMP Securitie, Wedbush PacGrow Life Sciences
Health Care
Filing(s):

Filed 2014-05-19
Terms Added 2014-06-09



Ardelyx Inc., Quote & Chart - Click for current quote - ARDX

About Ardelyx Inc., (adapted from Ardelyx Inc., prospectus):
They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, non-systemic, small molecule therapeutics that work exclusively in the gastrointestinal, or GI, tract to treat cardio-renal, GI and metabolic diseases.

This description is adapted from Ardelyx prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Ardelyx "ARDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved